Blue Sail Medical Co.,Ltd. (SHE:002382)
5.64
-0.02 (-0.35%)
Jun 12, 2025, 2:45 PM CST
Blue Sail Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -269.67 | -445.61 | -568.36 | -372.32 | 1,156 | 1,758 | Upgrade
|
Depreciation & Amortization | 526 | 526 | 524.51 | 489.01 | 332.16 | 213.71 | Upgrade
|
Other Amortization | 32.61 | 32.61 | 50.88 | 51.44 | 34.54 | 16.07 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.84 | 0.84 | 1.92 | -0.07 | 1.98 | -3.95 | Upgrade
|
Asset Writedown & Restructuring Costs | 6.29 | 6.29 | 21.47 | 6.94 | 2,069 | 1,775 | Upgrade
|
Loss (Gain) From Sale of Investments | 11.1 | 11.1 | -83.56 | -252.45 | -1,123 | -37.16 | Upgrade
|
Provision & Write-off of Bad Debts | 22.74 | 22.74 | 18.69 | 1.91 | 20.1 | 45.72 | Upgrade
|
Other Operating Activities | 301.14 | 235.02 | 233.45 | 161.99 | 188.73 | 206.56 | Upgrade
|
Change in Accounts Receivable | -311.05 | -311.05 | -247.61 | 413.41 | 182.7 | -582.56 | Upgrade
|
Change in Inventory | -207.17 | -207.17 | -146.32 | 176.54 | -426.52 | -342.93 | Upgrade
|
Change in Accounts Payable | 262.3 | 262.3 | 199.73 | -165.95 | -220.63 | 651.88 | Upgrade
|
Change in Other Net Operating Assets | 9.2 | 9.2 | 20.45 | 43.24 | 19.62 | - | Upgrade
|
Operating Cash Flow | 377.91 | 135.85 | -72.89 | 494.47 | 2,246 | 3,672 | Upgrade
|
Operating Cash Flow Growth | - | - | - | -77.98% | -38.84% | 369.03% | Upgrade
|
Capital Expenditures | -756.75 | -774.28 | -774.14 | -896.86 | -2,582 | -1,203 | Upgrade
|
Sale of Property, Plant & Equipment | 2.03 | 1.67 | 2.56 | 10.98 | 6.37 | 7.43 | Upgrade
|
Cash Acquisitions | - | - | - | -53.25 | - | -708.81 | Upgrade
|
Investment in Securities | -90.31 | 50.76 | -130.08 | 1,015 | 33.06 | -1,743 | Upgrade
|
Other Investing Activities | 10.07 | 6.42 | 30.91 | 38.74 | 49.45 | 4.07 | Upgrade
|
Investing Cash Flow | -834.96 | -715.44 | -870.75 | 114.82 | -2,493 | -3,643 | Upgrade
|
Long-Term Debt Issued | - | 1,644 | 1,040 | 142.76 | 1,477 | 4,391 | Upgrade
|
Total Debt Issued | 1,822 | 1,644 | 1,040 | 142.76 | 1,477 | 4,391 | Upgrade
|
Long-Term Debt Repaid | - | -1,824 | -393.24 | -793.42 | -1,984 | -2,525 | Upgrade
|
Total Debt Repaid | -1,851 | -1,824 | -393.24 | -793.42 | -1,984 | -2,525 | Upgrade
|
Net Debt Issued (Repaid) | -29.68 | -180.18 | 647.08 | -650.66 | -506.26 | 1,866 | Upgrade
|
Issuance of Common Stock | - | 0.02 | - | - | - | - | Upgrade
|
Repurchase of Common Stock | -929.98 | -30 | - | - | - | - | Upgrade
|
Common Dividends Paid | -168.42 | -177.44 | -513.78 | -61.02 | -477.2 | -282.13 | Upgrade
|
Other Financing Activities | 1,930 | 1,710 | - | -0.01 | 6.45 | 479.11 | Upgrade
|
Financing Cash Flow | 801.76 | 1,323 | 133.31 | -711.69 | -977.02 | 2,063 | Upgrade
|
Foreign Exchange Rate Adjustments | -13.28 | -7.22 | 20.56 | 59.63 | 48.07 | -87.64 | Upgrade
|
Net Cash Flow | 331.42 | 735.95 | -789.77 | -42.77 | -1,176 | 2,004 | Upgrade
|
Free Cash Flow | -378.84 | -638.43 | -847.03 | -402.39 | -336.22 | 2,468 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | - | 479.30% | Upgrade
|
Free Cash Flow Margin | -6.04% | -10.21% | -17.19% | -8.21% | -4.15% | 31.37% | Upgrade
|
Free Cash Flow Per Share | -0.38 | -0.63 | -0.83 | -0.40 | -0.32 | 2.43 | Upgrade
|
Cash Interest Paid | 3.75 | 3.75 | 3.93 | - | - | - | Upgrade
|
Cash Income Tax Paid | - | -314.21 | -270.3 | -540.33 | -69.07 | 266.74 | Upgrade
|
Levered Free Cash Flow | -1,006 | -1,106 | -994.93 | -866.98 | -48.7 | 968 | Upgrade
|
Unlevered Free Cash Flow | -822.9 | -931.72 | -882.14 | -786.05 | 34.62 | 1,087 | Upgrade
|
Change in Net Working Capital | 530.73 | 586.95 | 313.63 | 8.38 | -739.4 | 441.86 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.